日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Subtype-selective positron emission tomography imaging of poly ADP-ribose polymerase-1 binding in non-human primates, healthy volunteers, and patients with glioblastoma using [11C]AZ14193391

利用[11C]AZ14193391对非人灵长类动物、健康志愿者和胶质母细胞瘤患者进行亚型选择性正电子发射断层扫描成像,以检测聚ADP核糖聚合酶-1的结合情况。

Cselényi, Zsolt; Jucaite, Aurelija; Stragliotto, Giuseppe; Bartek, Jiri; Johnström, Peter; Pike, Andy; Cortés González, Miguel A; Högnäsbacka, Antonia; Dahl, Kenneth; Ghosh, Avipsa; Johannes, Jeffrey W; Staniszewska, Anna D; Leo, Elisabetta; Hamerlik, Petra; Davies, Barry; Cosulich, Sabina; Swales, John; Lawrence, Rachel; Squatrito, Massimo; Mueller, Nancy Kathryn; Khani, Yasir; Sousa, Vasco C; Stenkrona, Per; Halldin, Christer; Farde, Lars; Schou, Magnus

Deriving and comparing healthy longevity distributions by gender and health prevalence measures: a statistical moments and maximum entropy approach

基于统计矩和最大熵方法,推导和比较按性别和健康患病率指标划分的健康长寿分布。

Cosulich, Rami; di Lego, Vanessa; Zarulli, Virginia

AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertions.

AZ14289671 是一种高选择性且能穿透血脑屏障的不可逆 TKI,靶向 EGFRExon20 插入

Swaih Aisha M, Talbot Sara, Savoca Adriana, Thorpe Hannah, Flemington Vikki, Phillips Benjamin, Colclough Nicola, McCoull William, Radeva Veronika, Hargreaves David, Packer Martin J, Felisberto-Rodrigues Catarina, Thomson Clare, Orme Jonathan P, Deane Carly, Smith Aaron, Johnström Peter, Schou Magnus, McWilliams Lisa, Davey Paul, Enget Marianne, O'Neill Daniel, Cosulich Sabina, Floc'h Nicolas

Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers

AZD5335 的衍生化,一种新型的 FRα 靶向 TOP1i 负载抗体偶联药物 (ADC),用于治疗表达 FRα 的癌症

Zoeller, Jason J; Tammali, Ravinder; Dodd, Roger B; Patel, Neki V; Andoni, Alma; Bisha, Ina; Cronin, Shane; De Almeida, Ana; Lee, Nancy; Meekin, John H 3rd; Tilmont, Isabella; Gasper, Diana; Lan, Lingyun; Cox, Megan; Thomas, Tima; Ward, Christopher; Chesebrough, Jon; Anderton, Judith; Neal, Frances; Zenonos, Zenon; Shandilya, Harini; Chooi, K Phin; Pugh, Kathryn; Saleh, Ali; Wang, Jixin; Mitchell, Pat; Naseer, Humaira; Beaumont, Kevin; Hood, John; Myers, Claire; Christ, Simon; Dino, Iris; Guza, Xhenifer; Falck, Tillmann; Lehmann, Michael; Sargeant, Rebecca; Godfrey, Lisa; Recolin, Benedicte; Brier, Tim; Turner, Simon; Rosfjord, Edward; Fraenkel, Paula G; Cosulich, Sabina; Gymnopoulos, Marco; Hurt, Elaine; Sapra, Puja

Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer

克隆体细胞拷贝数改变的驱动事件可提示高级别浆液性卵巢癌的药物敏感性

Filipe Correia Martins #,Dominique-Laurent Couturier #,Ines de Santiago,Carolin Margarethe Sauer,Maria Vias,Mihaela Angelova,Deborah Sanders,Anna Piskorz,James Hall,Karen Hosking,Anumithra Amirthanayagam,Sabina Cosulich,Larissa Carnevalli,Barry Davies,Thomas B K Watkins,Ionut G Funingana,Helen Bolton,Krishnayan Haldar,John Latimer,Peter Baldwin,Robin Crawford,Matthew Eldridge,Bristi Basu,Mercedes Jimenez-Linan,Andrew W Mcpherson,Nicholas McGranahan,Kevin Litchfield,Sohrab P Shah,Iain McNeish,Carlos Caldas,Gerard Evan,Charles Swanton,James D Brenton

Acyl chain selection couples the consumption and synthesis of phosphoinositides

酰基链选择与磷酸肌醇的消耗和合成相结合

David Barneda, Vishnu Janardan, Izabella Niewczas, Daniel M Collins, Sabina Cosulich, Jonathan Clark, Len R Stephens #, Phillip T Hawkins #

Genome-Wide Estrogen Receptor Activity in Breast Cancer

乳腺癌中全基因组雌激素受体活性

Farcas, Anca M; Nagarajan, Sankari; Cosulich, Sabina; Carroll, Jason S

AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival

AKT/mTORC2 抑制可激活 CLL 细胞中的 FOXO1 功能,从而降低 B 细胞受体介导的存活率

Emilio Cosimo, Anuradha Tarafdar, Michael W Moles, Ailsa K Holroyd, Natasha Malik, Mark A Catherwood, Jodie Hay, Karen M Dunn, Alan M Macdonald, Sylvie M Guichard, Declan O'Rourke, Michael T Leach, Owen J Sansom, Sabina C Cosulich, Alison M McCaig, Alison M Michie

Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer

mTORC1/2 抑制剂 vistusertib 与氟维司群在体内和体外联合治疗雌激素受体阳性的内分泌抗性乳腺癌

Sunil Pancholi, Mariana Ferreira Leal, Ricardo Ribas, Nikiana Simigdala, Eugene Schuster, Sophie Chateau-Joubert, Lila Zabaglo, Margaret Hills, Andrew Dodson, Qiong Gao, Stephen R Johnston, Mitch Dowsett, Sabina C Cosulich, Elisabetta Maragoni, Lesley-Ann Martin

How is the acyl chain composition of phosphoinositides created and does it matter?

磷酸肌醇的酰基链组成是如何形成的?它重要吗?

Barneda, David; Cosulich, Sabina; Stephens, Len; Hawkins, Phillip